Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fructosin for fructose malabsorption
2008-005861-80Phase 2Completed
- Sponsor
- Sciotec Diagnostic Technologies
- Start
- Nov 2008
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of fructosin in Fructose malabsorption (DFI), sponsored by Sciotec Diagnostic Technologies. Primary endpoints: Reduction in breath hydrogen after fructose intake and Clinical symptoms and safety. Started Nov 2008; status: completed.
02
Drugs
fructosin
03
Conditions
Fructose malabsorption (DFI)
Beyond the preview
Go deeper on 2008-005861-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005861-80.